BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 107 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $6,425,000 | +6.1% | 82,309 | -13.7% | 3.01% | +11.0% |
| Q2 2018 | $6,053,000 | -39.8% | 95,352 | -13.0% | 2.71% | -41.7% |
| Q1 2018 | $10,055,000 | -1.7% | 109,652 | -19.1% | 4.66% | -0.1% |
| Q4 2017 | $10,224,000 | -14.6% | 135,585 | -21.1% | 4.66% | -9.3% |
| Q3 2017 | $11,971,000 | -22.2% | 171,822 | -43.4% | 5.14% | -28.4% |
| Q2 2017 | $15,385,000 | -21.9% | 303,641 | -38.3% | 7.18% | -27.6% |
| Q1 2017 | $19,689,000 | +0.1% | 492,341 | -29.8% | 9.92% | -6.7% |
| Q4 2016 | $19,663,000 | – | 700,991 | – | 10.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 878,875 | $70,354,000 | 45.87% |
| CVI Holdings, LLC | 200,000 | $16,010,000 | 15.16% |
| Foresite Capital Management III, LLC | 467,682 | $37,438,000 | 9.74% |
| Casdin Capital, LLC | 848,648 | $67,934,000 | 7.46% |
| BVF INC/IL | 564,965 | $45,225,000 | 5.06% |
| Ghost Tree Capital, LLC | 240,000 | $19,212,000 | 5.02% |
| DAFNA Capital Management LLC | 119,718 | $9,583,000 | 4.13% |
| HHLR ADVISORS, LTD. | 1,498,516 | $119,956,000 | 3.34% |
| Opaleye Management Inc. | 130,000 | $10,407,000 | 2.88% |
| Perceptive Advisors | 1,271,054 | $101,748,000 | 2.87% |